EdgarLookup

Kyverna Therapeutics, Inc. — 8-K Filings

30 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Kyverna Therapeutics, Inc. (KYTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Kyverna Therapeutics, Inc. has filed 30 8-K documents with the SEC since 2023. To view all SEC filings by Kyverna Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 424B4 424B5 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP S-1 S-1/A S-3 S-8 SC 13D SC 13G SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K 8-K 0001193125-26-126216 Mar 26, 2026
8-K 8-K 0001193125-26-065320 Feb 24, 2026
8-K 8-K 0001193125-26-034464 Feb 3, 2026 Jan 29, 2026
8-K 8-K 0001193125-26-009810 Jan 12, 2026 Jan 8, 2026
8-K CURRENT REPORT 0001213900-25-123033 Dec 18, 2025 Dec 17, 2025
8-K 8-K 0001193125-25-318469 Dec 15, 2025
8-K 8-K 0001193125-25-318377 Dec 15, 2025
8-K 8-K 0001193125-25-277569 Nov 12, 2025
8-K 8-K 0001193125-25-261719 Nov 3, 2025 Nov 2, 2025
8-K 8-K 0001193125-25-254698 Oct 29, 2025
8-K 8-K 0001193125-25-254571 Oct 29, 2025
8-K 8-K 0001193125-25-217434 Sep 25, 2025 Sep 19, 2025
8-K 8-K 0000950170-25-107300 Aug 12, 2025
8-K CURRENT REPORT 0001213900-25-059289 Jun 30, 2025
8-K 8-K 0000950170-25-080896 Jun 3, 2025 May 29, 2025
8-K 8-K 0000950170-25-070286 May 13, 2025
8-K 8-K 0000950170-25-046176 Mar 27, 2025
8-K 8-K 0000950170-25-046052 Mar 27, 2025
8-K 8-K 0000950170-25-007220 Jan 21, 2025
8-K CURRENT REPORT 0001213900-25-002831 Jan 13, 2025
8-K 8-K 0000950170-24-131074 Nov 26, 2024
8-K 8-K 0000950170-24-126342 Nov 13, 2024 Nov 8, 2024
8-K CURRENT REPORT 0001213900-24-089095 Oct 21, 2024 Oct 20, 2024
8-K CURRENT REPORT 0001213900-24-078736 Sep 16, 2024 Sep 13, 2024
8-K 8-K 0000950170-24-095433 Aug 12, 2024
8-K 8-K 0000950170-24-083570 Jul 15, 2024
8-K 8-K 0000950170-24-073312 Jun 14, 2024
8-K 8-K 0000950170-24-059613 May 14, 2024
8-K 8-K 0000950170-24-036410 Mar 26, 2024
8-K 8-K 0001193125-24-032161 Feb 12, 2024